Literature DB >> 22901129

siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells.

Wei-Yi Huang1, Dong-Hui Chen, Li Ning, Li-Wei Wang.   

Abstract

The gene encoding the Nin one binding (NOB1) protein which plays an essential role in protein degradation has been investigated for possible tumor promoting functions. The present study was focused on NOB1 as a possible therapeutic target for breast cancer treatment. Lentivirus mediated NOB1 siRNA transfection was used to silence the NOB1 gene in two established breast cancer cell lines, MCF-7 and MDA-MB-231, successful transfection being confirmed by fluorescence imaging. NOB1 deletion caused significant decline in cell proliferation was observed in both cell lines as investigated by MTT assay. Furthermore the number and size of the colonies formed were also significantly reduced in the absence of NOB1. Moreover NOB1 gene knockdown arrested the cell cycle and inhibited cell cycle related protein expression. Collectively these results indicate that NOB1 plays an essential role in breast cancer cell proliferation and its gene expression could be a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901129     DOI: 10.7314/apjcp.2012.13.5.1823

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  3 in total

1.  Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells.

Authors:  Xiangmin Zhang; Dongxu Zhang; Fajun Qu; Yi Hong; Jianwei Cao; Xiuwu Pan; Lin Li; Yi Huang; Hai Huang; Lei Yin; Lu Chen; Jizhong Ren; Zhijun Wang; Danfeng Xu; Xingang Cui
Journal:  Mol Cell Biochem       Date:  2014-08-29       Impact factor: 3.396

2.  Expression of Concern: shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells.

Authors:  Hongjian Yang; Yue Lu; Yabing Zheng; Xingfei Yu; Xianghou Xia; Xiangming He; Weiliang Feng; Lei Xing; Zhiqiang Ling
Journal:  Cancer Chemother Pharmacol       Date:  2020-06       Impact factor: 3.333

3.  NOB1 in non-small-cell lung cancer: expression profile and clinical significance.

Authors:  Kun Liu; Ming-Ming Gu; Hong-Lin Chen; Qing-Sheng You
Journal:  Pathol Oncol Res       Date:  2013-11-23       Impact factor: 3.201

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.